Filter results
You can narrow down the results using the filters
Topics
Our work
Diseases
11615 results
-
Aboriginal and Torres Strait Islander Advisory Group on COVID-19 communique – 15 October 2020
This communique summarises the meeting of the Aboriginal and Torres Strait Islander Advisory Group on COVID-19 held on 15 October 2020. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type I (MPS I)
A collection of resources for health professionals to help people with mucopolysaccharidosis type I (MPS I) access laronidase (Aldurazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type II (MPS II)
A collection of resources for health professionals to help people with mucopolysaccharidosis type II (MPS II) access idursulfase (Elaprase®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type IVA (MPS IVA)
A collection of resources for health professionals to help people with mucopolysaccharidosis type IVA (MPS IVA) access elosulfase alfa (Vimizim®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Mucopolysaccharidosis type VI (MPS VI)
A collection of resources for health professionals to help people with mucopolysaccharidosis type VI (MPS VI) access galsulfase (Naglazyme®) under the Life Saving Drugs Program (LSDP). -
Life Saving Drugs Program resources – Pompe disease
A collection of resources for health professionals to help people with Pompe disease access alglucosidase alfa (Myozyme®) and avalglucosidase alfa (Nexviazyme®) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Hereditary tyrosinaemia type 1
A collection of resources for health professionals to help people with hereditary tyrosinaemia type 1 access nitisinone (Orfadin® and Nityr™) under the Life Saving Drugs Program. -
Life Saving Drugs Program resources – Late-Infantile onset batten disease (CLN2 disease)
A collection of resources for health professionals to help people with CLN2 disease access cerliponase alfa (Brineura®) under the Life Saving Drugs Program. -
Coronavirus (COVID-19) at a glance – 14 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 14 October 2020. -
Support for Australia’s thalidomide survivors
Australian Government response to the Senate Community Affairs References Committee inquiry into support for Australia’s thalidomide survivors -
Coronavirus (COVID-19) at a glance – 13 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 13 October 2020. -
Post-market validation of a further two serological assays for COVID-19 – updated report
This report present results of post-market validation of a further 2 serological assays for the detection of SARS-CoV-2 antibodies. -
COVID-19 and the particular risks for people with disability – Roundtable – Minutes and actions arising 13 October 2020
This communique outlines the issues discussed and key actions following the seventh Roundtable meeting on 13 October 2020. A representative from Deaf Australia provided an presentation on the experiences of the deaf community. -
Coronavirus (COVID-19) at a glance – 12 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 12 October 2020. -
National Notifiable Diseases Surveillance System (NNDSS) fortnightly reports – 12 to 25 September 2020
This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 12 to 25 September 2020. -
Coronavirus (COVID-19) at a glance – 11 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 11 October 2020. -
Coronavirus (COVID-19) at a glance – 9 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 9 October 2020. -
Coronavirus (COVID-19) at a glance – 10 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 10 October 2020. -
Aged Care System Navigator (ACSN) Measure Interim Evaluation Report – Executive summary
This report provides information on the progress of the ACSN measure trials. The measure is testing different models to help people understand and engage with the aged care system for people who have had difficulty in accessing the services they need. -
Aged Care System Navigator (ACSN) Measure Interim Evaluation Report – review of other system navigator models
This report provides information on system navigator models for aged care and in other sectors that exist in Australia and internationally. -
COVID-19 outbreaks in Australian residential aged care facilities – 9 October 2020
This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services. -
Coronavirus (COVID-19) common operating picture – 8 October 2020
This infographic provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia issued on 8 October 2020. -
AISR fortnightly report no. 13 – 21 September to 4 October 2020
The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons. -
Life Saving Drugs Program – Fabry disease – Patient test results spreadsheet
Specialists use this spreadsheet to report their patient's test results when reapplying for treatment under the Life Saving Drugs Program. -
Coronavirus (COVID-19) at a glance – 8 October 2020
This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 8 October 2020.